Advertisement
Screener

Biomea Fusion, Inc. (BMEA) Increase Decrease In Operating Lease Liability

Biomea Fusion, Inc. Increase Decrease In Operating Lease Liability

Biomea Fusion, Inc. (BMEA) reported Increase Decrease In Operating Lease Liability of -$712.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-05

  • Biomea Fusion, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$362.00K.
  • Biomea Fusion, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$350.00K.
  • Biomea Fusion, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$282.00K.
  • Biomea Fusion, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$177.00K.
  • Biomea Fusion, Inc. increase decrease in operating lease liability for fiscal 2025 was -$2.18M.
  • Biomea Fusion, Inc. increase decrease in operating lease liability for fiscal 2024 was -$1.50M.
  • Biomea Fusion, Inc. increase decrease in operating lease liability for fiscal 2023 was -$2.24M.
  • Biomea Fusion, Inc. increase decrease in operating lease liability for fiscal 2022 was -$565.00K.
Period endIncrease Decrease In Operating Lease Liability 3 monthIncrease Decrease In Operating Lease Liability 6 monthIncrease Decrease In Operating Lease Liability 9 monthIncrease Decrease In Operating Lease Liability 12 month
2026-06-30-$362.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$712.00K
10-Q · filed 2026-08-05
-$994.00K
derived: sum of 3 quarters · filed 2026-08-05
-$1.17M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$350.00K
10-Q · filed 2026-05-11
-$632.00K
derived: sum of 2 quarters · filed 2026-05-11
-$809.00K
derived: sum of 3 quarters · filed 2026-05-11
-$1.68M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$282.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
-$459.00K
derived: sum of 2 quarters · filed 2026-03-24
-$1.33M
derived: sum of 3 quarters · filed 2026-08-05
-$2.18M
10-K · filed 2026-03-24
2025-09-30-$177.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$1.05M
derived: sum of 2 quarters · filed 2026-08-05
-$1.90M
10-Q · filed 2025-11-04
-$2.69M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$874.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$1.72M
10-Q · filed 2026-08-05
-$2.51M
derived: sum of 3 quarters · filed 2026-08-05
-$3.29M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$844.00K
10-Q · filed 2026-05-11
-$1.64M
derived: sum of 2 quarters · filed 2026-05-11
-$2.41M
derived: sum of 3 quarters · filed 2026-05-11
-$2.84M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31-$795.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
-$1.57M
derived: sum of 2 quarters · filed 2026-03-24
-$2.00M
derived: sum of 3 quarters · filed 2026-03-24
-$1.50M
10-K · filed 2026-03-24
2024-09-30-$775.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$1.21M
derived: sum of 2 quarters · filed 2025-11-04
-$706.00K
10-Q · filed 2025-11-04
-$1.11M
derived: sum of 4 quarters · filed 2026-03-24
2024-06-30-$430.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$69.00K
10-Q · filed 2025-08-05
-$339.00K
derived: sum of 3 quarters · filed 2026-03-24
-$977.00K
derived: sum of 4 quarters · filed 2026-03-24
2024-03-31$499.00K
10-Q · filed 2025-05-05
$91.00K
derived: sum of 2 quarters · filed 2026-03-24
-$547.00K
derived: sum of 3 quarters · filed 2026-03-24
-$1.16M
derived: sum of 4 quarters · filed 2026-03-24
2023-12-31-$408.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
-$1.05M
derived: sum of 2 quarters · filed 2026-03-24
-$1.66M
derived: sum of 3 quarters · filed 2026-03-24
-$2.24M
10-K · filed 2026-03-24
2023-09-30-$638.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
-$1.25M
derived: sum of 2 quarters · filed 2024-10-29
-$1.83M
10-Q · filed 2024-10-29
-$1.98M
derived: sum of 4 quarters · filed 2025-03-31
2023-06-30-$617.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
-$1.19M
10-Q · filed 2024-07-31
-$1.34M
derived: sum of 3 quarters · filed 2025-03-31
-$1.48M
derived: sum of 4 quarters · filed 2025-03-31
2023-03-31-$575.00K
10-Q · filed 2024-05-02
-$721.00K
derived: sum of 2 quarters · filed 2025-03-31
-$865.00K
derived: sum of 3 quarters · filed 2025-03-31
-$1.00M
derived: sum of 4 quarters · filed 2025-03-31
2022-12-31-$146.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$290.00K
derived: sum of 2 quarters · filed 2025-03-31
-$430.00K
derived: sum of 3 quarters · filed 2025-03-31
-$565.00K
10-K · filed 2025-03-31
2022-09-30-$144.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30
-$284.00K
derived: sum of 2 quarters · filed 2023-10-30
-$419.00K
10-Q · filed 2023-10-30
-$554.00K
derived: sum of 4 quarters · filed 2024-03-28
2022-06-30-$140.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31
-$275.00K
10-Q · filed 2023-07-31
-$410.00K
derived: sum of 3 quarters · filed 2024-03-28
-$476.00K
derived: sum of 4 quarters · filed 2024-03-28
2022-03-31-$135.00K
10-Q · filed 2023-05-02
-$270.00K
derived: sum of 2 quarters · filed 2024-03-28
-$336.00K
derived: sum of 3 quarters · filed 2024-03-28
-$638.00K
derived: sum of 4 quarters · filed 2024-03-28
2021-12-31-$135.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
-$201.00K
derived: sum of 2 quarters · filed 2024-03-28
-$503.00K
derived: sum of 3 quarters · filed 2024-03-28
-$589.00K
10-K · filed 2024-03-28
2021-09-30-$66.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
-$368.00K
derived: sum of 2 quarters · filed 2022-11-07
-$454.00K
10-Q · filed 2022-11-07
2021-06-30-$302.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01
-$388.00K
10-Q · filed 2022-08-01
2021-03-31-$86.00K
10-Q · filed 2022-05-16
2020-12-31-$111.00K
10-K · filed 2023-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Equillium, Inc. (EQ)United States$0.109B-11.27
GENELUX Corp (GNLX)United States$0.110B-3.83
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
ProMIS Neurosciences Inc. (PMN)$0.102B
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Anixa Biosciences Inc (ANIX)United States$0.096B